PATENT CLAIM ANALYSIS

Application Number: 15879802
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "043000"]

Abstract:
The invention provides derivatives of decitabine with superior chemical stability and shelf life, with similar physiological activity. The derivatives are provided in a non-aqueous formulation, which further stabilizes the derivatives. Methods of treating one or more myelodysplastic syndromes, leukemia, or solid tumours using the formulations are described.

Claim (Index 36):
The composition of  claim 35 , wherein the composition comprises about 60% to about 70% propylene glycol (w/w).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14241635', '15174386', '10164276', '10890621', '13878994']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7345229150075907
- 35 USC 102 Novelty (BERT): 0.5270713743717007
- Combined Prediction Score: 0.7137777609440017
- Mean Citation Score: 240.15071000000003
- Max Citation Score: 307.86505
- Similarity Product: 214.7484943675876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test